{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:07:41Z","timestamp":1780376861079,"version":"3.54.1"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004870","name":"Medizinische Fakult\u00e4t,\u00a0Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Superficial\n                      <jats:italic>ALK-<\/jats:italic>\n                      rearranged soft tissue tumors are rare mesenchymal neoplasms showing heterogenous morphology and clinical behavior. They usually present as slowly enlarging nodules in young adults and can mimic other spindle cell tumors. While some\n                      <jats:italic>ALK<\/jats:italic>\n                      -altered mesenchymal neoplasms can be classified into defined WHO categories (e.g., inflammatory myofibroblastic tumor, epithelioid fibrous histiocytoma, and a few others), the nosology of many tumors has not yet been delineated, and they are currently reported descriptively. A case of a young man with a three-year follow-up is presented, providing prognostic insights into this entity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>\n                      A healthy 23-year-old male presented with a purplish mass on the plantar left foot that had enlarged over one year. MRI showed a well-defined lesion without bone involvement. Histopathology revealed sheets of bland round to oval cells within myxohyaline stroma containing focal pseudorosette-like hyalinized nodules and increased mitotic activity. Immunohistochemistry demonstrated strong cytoplasmic ALK expression with heterogeneous expression for CD34, and S100. Focal EMA and pancytokeratin expression were noted. Next-generation sequencing confirmed a\n                      <jats:italic>MYH10::ALK<\/jats:italic>\n                      fusion. After excision with positive margins, re-excision revealed residual tumor as well. Further surgery was declined, and the patient developed metastatic disease during follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This case broadens the spectrum of acral\n                      <jats:italic>ALK<\/jats:italic>\n                      -rearranged unclassified mesenchymal tumors and identifies\n                      <jats:italic>MYH10<\/jats:italic>\n                      as a potential fusion partner in metastatic disease. Although these tumors are typically indolent, features such as increased mitotic activity may indicate more aggressive behavior. Diagnosis requires integrated histologic, immunophenotypic, and molecular assessment. This case highlights the metastatic potential of\n                      <jats:italic>ALK<\/jats:italic>\n                      -rearranged unclassified mesenchymal neoplasms, particularly those exhibiting a tyrosine kinase phenotype (co-expression of S100 and CD34), supporting their classification within the intermediate, rarely metastasizing category according to soft tissue tumor stratification principles. It further emphasizes the need for heightened clinical vigilance and thorough surgical management, which may influence long-term outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1835779","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:28:50Z","timestamp":1780374530000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Acral MYH10::ALK fusion superficial mesenchymal neoplasm: first proof of metastatic potential"],"prefix":"10.3389","volume":"16","author":[{"given":"Masih","family":"Kameh Khosh","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, University Hospital Muenster","place":["Muenster, Germany"]},{"name":"Department of Plastic, Reconstructive and Aesthetic Surgery, Hand Surgery, Hornheide Specialist Clinic","place":["Muenster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Wellenbrock","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, University Hospital Muenster","place":["Muenster, Germany"]},{"name":"Department of Plastic, Reconstructive and Aesthetic Surgery, Hand Surgery, Hornheide Specialist Clinic","place":["Muenster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kameh Khosh","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Sciences, University of Antwerp","place":["Antwerp, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, University Hospital Muenster","place":["Muenster, Germany"]},{"name":"Department of Plastic, Reconstructive and Aesthetic Surgery, Hand Surgery, Hornheide Specialist Clinic","place":["Muenster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuernberg, University Hospital","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Mon","family":"O'Dey","sequence":"additional","affiliation":[{"name":"O'Dey Private Practice: Plastic & Hand Surgery, Salutem Private Clinic","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00830-w","article-title":"Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile","volume":"34","author":"Dermawan","year":"2021","journal-title":"Mod Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/gcc.23097","article-title":"ALK-rearranged mesenchymal neoplasms: a report of 9 cases further expanding the clinicopathologic spectrum of emerging kinase fusion positive group of tumors","volume":"62","author":"Dermawan","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1516491","article-title":"Case report: ALK-rearranged mesenchymal neoplasms with S100 and CD34 co-expression: additional cases with distinct characteristics","volume":"15","author":"Ouyang","year":"2025","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12083038","article-title":"Malignant bone and soft tissue lesions of the foot","volume":"12","author":"Angelini","year":"2023","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jos.2020.08.016","article-title":"Clinical features of bone and soft tissue tumors of the foot and ankle: results from a retrospective single-center case-series","volume":"26","author":"Murahashi","year":"2021","journal-title":"J Orthop Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semdp.2025.150947","article-title":"The expanding family of ALK-rearranged mesenchymal neoplasms","volume":"42","author":"Agaimy","year":"2025","journal-title":"Semin Diagn Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100334","article-title":"ALK-rearranged epithelioid mesenchymal neoplasm: expanding the spectrum of tyrosine kinase-altered mesenchymal tumors","volume":"36","author":"Gestrich","year":"2023","journal-title":"Mod Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/his.14603","article-title":"ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney","volume":"80","author":"Tan","year":"2022","journal-title":"Histopathology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001887","article-title":"S100 and CD34 expressing mesenchymal neoplasm with rare PLEKHH2::ALK fusion and response to ALK inhibition","volume":"46","author":"Coppock","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0330-OA","article-title":"ALK translocation in ALK-positive mesenchymal tumors: diagnostic and therapeutic insights","volume":"146","author":"Jung","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04198-z","article-title":"ALK rearranged Malignant mesenchymal neoplasms of thorax: therapeutically targetable \u201cALKomas\u201d beyond the spectrum of non-small cell lung carcinomas and thoracic inflammatory myofibroblastic tumors","author":"Sadhu","year":"2025","journal-title":"Virchows Arch"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04345-6","article-title":"Orthogonal validation of anaplastic lymphoma kinase (ALK) immunohistochemistry with molecular analysis for ALK gene rearrangement is required to finetune staining protocols with the D5F3 clone and can impact external quality assessment","author":"Kassem","year":"2025","journal-title":"Virchows Arch"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684865","article-title":"Crizotinib in sarcomatous Malignancies harboring ALK fusion with a definitive partner(s): response and efficacy","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1835779\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:28:55Z","timestamp":1780374535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1835779\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":14,"alternative-id":["10.3389\/fonc.2026.1835779"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1835779","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"article-number":"1835779"}}